Peptide
CJC-1295 with DAC
SaveCJC-1295 conjugated with a Drug Affinity Complex that binds albumin, extending plasma half-life to ~8 days and producing sustained GH elevation.
Quick verdict
Produces more continuous (less pulsatile) GH elevation than CJC-1295 without DAC. Some clinicians prefer the non-DAC version for a more physiologic GH pulse pattern.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Human PK studies confirm prolonged GH elevation. The blunted pulsatility is considered less physiologic by some researchers.
Benefits
- Extended half-life reduces injection frequency
- Confirmed sustained GH and IGF-1 elevation in humans
Dosage notes
Typical protocols: 1–2 mg subcutaneously once or twice weekly.
Side effects
- Water retention
- Flushing
- Headache
- Injection-site reactions
- Joint stiffness
Who should be cautious
Not FDA-approved. Chronic non-pulsatile GH elevation may carry different risks than pulsatile release.
What this page cannot tell you
Clinical outcome data are sparse. The DAC version is less commonly recommended in current anti-aging protocols.
Leaderboard scores
- Muscle38
- Recovery30
- Longevity22
Write a review
Sign in to write a review.